Chai Discovery
Backed by
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Explore similar companies to Chai Discovery
Candid Health
Easy, automated medical billing.
Biotech · Series C · Onsite · Based in San Francisco
Latent Labs
Making biology programmable.
Biotech · Series A · Remote · Based in London
Invert
Modern software for bioprocess data.
Biotech · Seed · Remote · Based in San Francisco
Sway
Seaweed as replacement for plastic.
Biotech · Seed · Remote · Based in San Francisco
Colossal
The de-extinction company.
Biotech · Series C · Remote · Based in Dallas
Salt
AI for life sciences.
Biotech · Series A · Remote · Based in Los Angeles
Until
Developing reversible cryopreservation.
Biotech · Series A · Onsite · Based in San Francisco
Nudge
Whole-brain interfaces for everyday life.
Biotech · Series A · Onsite · Based in San Francisco
NewLimit
Extending human healthspan.
Biotech · Series B · Onsite · Based in San Francisco
Industries
Investors
Cities